G279-0256 Screening compound: 4-{2-[4-(4-fluorophenyl)piperazin-1-yl]-2-oxoethyl}-3-methyl-1-phenyl-1H,4H,5H,6H-pyrazolo[3,4-b][1,4]thiazin-5-one

G279-0256 Screening compound: 4-{2-[4-(4-fluorophenyl)piperazin-1-yl]-2-oxoethyl}-3-methyl-1-phenyl-1H,4H,5H,6H-pyrazolo[3,4-b][1,4]thiazin-5-one
G279-0256 Screening compound: 4-{2-[4-(4-fluorophenyl)piperazin-1-yl]-2-oxoethyl}-3-methyl-1-phenyl-1H,4H,5H,6H-pyrazolo[3,4-b][1,4]thiazin-5-one alternative view

Chemical Structure Depiction of ChemDiv screening compound G279-0256
4-{2-[4-(4-fluorophenyl)piperazin-1-yl]-2-oxoethyl}-3-methyl-1-phenyl-1H,4H,5H,6H-pyrazolo[3,4-b][1,4]thiazin-5-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G279-0256

Molecular Formula

C24H24FN5O2S (C24 H24 FN5 O2 S)

Compound Name

4-{2-[4-(4-fluorophenyl)piperazin-1-yl]-2-oxoethyl}-3-methyl-1-phenyl-1H,4H,5H,6H-pyrazolo[3,4-b][1,4]thiazin-5-one

IUPAC name

4-{2-[4-(4-fluorophenyl)piperazin-1-yl]-2-oxoethyl}-3-methyl-1-phenyl-1H4H5H6H-pyrazolo[34-b][14]thiazin-5-one

SMILES

Cc(c(N1CC(N(CC2)CCN2c(cc2)ccc2F)=O)c2SCC1=O)nn2-c1ccccc1

InChI

InChI=1S/C24H24FN5O2S/c1-17-23-24(30(26-17)20-5-3-2-4-6-20)33-16-22(32)29(23)15-21(31)28-13-11-27(12-14-28)19-9-7-18(25)8-10-19/h2-10H,11-16H2,1H3

InChI Key

RMNUDQGWCZCIKH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14993364

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

465.55

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.625

Distribution Coefficient, logD

2.625

Water Solubility, LogSw

-2.82

Polar Surface Area

49.221

Acid Dissociation Constant (pKa)

18.77

Base Dissociation Constant (pKb)

5.49

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.20

G279-0256 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Antiviral Annotated Library (21441 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein-Protein Interaction Library (218420 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with G279-0256 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G279-0256?
Check Price and Availability of G279-0256, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G279-0256 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G279-0256
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G279-0256
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G279-0256 available by request